SAN DIEGO, March 06, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and ...

Good day, everyone, and welcome to today's Arcturus Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later ...

Analysts' ratings for Arcturus Therapeutics (NASDAQ:ARCT) over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below offers a condensed view of their recent ...

Neither are especially elegant solutions. Then there's Orion, Meta's in-development AR glasses. In a recent blog post, Meta claimed, "Orion combines the benefits of a large holographic display and ...

DUBAI, United Arab Emirates, March 07, 2025 (GLOBE NEWSWIRE) -- Orion Funded has announced the launch of Orion V2, an update to its proprietary trading program that introduces new funding models, an ...

Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) focuses on innovation and strategic partnerships to bolster its pipeline and financial position. SAN DIEGO (AP) — Arcturus ...

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on UMS Holdings (UMSSF – Research Report), Orion Group Holdings (ORN – Research Report ...

A nerdy dive into Meta’s Orion glasses. A weekly newsletter by David Pierce designed to tell you everything you need to download, watch, read, listen to, and explore that fits in The Verge’s ...

Let's move on to an even more pressing issue of intelligence. The French optical-electronic reconnaissance satellites Pleiades-1A (Pleiades-1A) and Pleiades-1B (Pleiades-1B), prepared and adjusted by ...